A case of recurrent esophageal cavernous hemangioma increasing rapidly after surgery

Abstract

A 40-year-old female was referred to our hospital for dysphagia. A hemangioma measuring 5 x 2.5 x 2.5 cm was revealed as a round defect by esophagography and was partially cystic on CT and MRI. Through a neck incision, the esophageal wall on the tumor side was initially opened. The tumor partially adhered to the esophageal wall, but was dissected from the esophageal wall and then resected easily. Microscopic examination of tumor revealed cavernous hemagioma. Thirty days after the initial surgery, the recurrent tumor was detected in the pharynx and increased rapidly. Then a second operation was performed. The tumor was completely resected by mucosectomy including normal esophageal mucosa. Recurrence was caused by residual cystic wall of the hemangioma adhering to the esophageal mucosa after the first procedure.

Successful en bloc resection of an esophageal hemangioma by endoscopic submucosal dissection

“…However, because conventional endoscopic therapy cannot obtain specimens for pathological examination and is associated with a risk of residual or recurrent hemangioma [4], en bloc removal is another possible treatment option. We report here the first case of a submucosal esophageal hemangioma successfully removed en bloc by endoscopic submucosal dissection (ESD).…”

Endoscopic Submucosal Dissection: A Safe and Effective Alternative to Surgical Intervention for Esophageal Hemangioma

“…22 EMR is associated with more bleeding when used for resecting hemangiomas, which is not the case in ESD. 23 Moreover, EMR could be applied repeatedly to avoid recurrence. 19 In addition to that, other methods such as sclerotherapy and argon plasma coagulation would not provide an excisional biopsy for histopathological examination, and en bloc removal is better.…”

Successful en bloc resection of an esophageal hemangioma by combined EBL & EMR: a case report and technical review

“…Because, conventional endoscopic therapy cannot obtain specimens for pathological examination and is associated with a risk residual or recurrent hemangioma (11).…”